When states require insurers to cover mental and behavioral health, children get better access to care, according to a UC San Francisco-led study of nearly 30,000 U.S. caregivers.
ESMO 2023: MSD’s Welireg leads HIF-2α inhibitors in RCC despite unclear OS – Pharmaceutical Technology
Welireg was reported to have a well-tolerated safety profile similar to that of Afinitor while having a longer time to function deterioration for better patient
October 23, 2023